FDA goes af­ter web­sites mar­ket­ing 'u­nap­proved' semaglu­tide, tirzepatide

The FDA has is­sued warn­ings to two web­sites mar­ket­ing “re­search chem­i­cals” that pur­port­ed­ly con­tain semaglu­tide and tirzepatide, the ac­tive in­gre­di­ents be­hind No­vo Nordisk and Eli Lil­ly’s block­buster weight loss and di­a­betes drugs.

US Chem Labs and Syn­thetix (do­ing busi­ness as He­lix Chem­i­cal Sup­ply) la­bel their prod­ucts “for re­search use on­ly,” but reg­u­la­tors said in warn­ing let­ters that the “un­ap­proved” and “mis­brand­ed” drugs were clear­ly ad­ver­tised for hu­man use.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER